Office Blood Pressure Changes and Control Transitions over Six Months in a Retrospective Hypertension Cohort
Year: 2026
Type: article
Abstract: Background and Objectives: Mean blood pressure (BP) changes can conceal individual gains and losses of control. We described six-month office BP control transitions and recorded treatment-class changes, and explored the association between baseline adiponectin and six-month non-control with adjustment for kidney function. Materials and Methods: This retrospective secondary analysis included 125 adults with hypertension. Uncontrolled BP was defined as systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg. Paired analyses and control-state transitions used available follow-up data. Exploratory logistic models included age, baseline systolic BP, and sex, with additional adiponectin, estimated glomerular filtration rate (eGFR), and treatment sensitivity analyses. Multiplicity and selection-related optimism were examined. Results: Six-month BP was available for 91 participants. Control increased from 31/91 (34.1%) to 46/91 (50.5%; exact McNemar p = 0.020): 20 remained controlled, 26 achieved control, 11 lost control, and 34 remained uncontrolled. Mean paired systolic BP fell by 6.81 mmHg (95% confidence interval (CI) −11.47 to −2.16). Among 32 persistently uncontrolled participants with paired complete medication profiles, 4 had a net class-count increase. In 78 participants with adiponectin data, the adjusted odds ratio per doubling was 2.60 (95% CI 1.25–5.38); additional eGFR adjustment did not attenuate the estimate (2.70, 1.28–5.67). The univariable association did not survive false-discovery-rate correction (q = 0.094), and selection-inclusive internal validation did not establish stable incremental discrimination. Conclusions: Net improvement in office BP control coexisted with loss of control in 11/31 initially controlled attendees. Recorded class-count changes cannot establish therapeutic inertia or a programme effect. The adiponectin association remained exploratory after renal adjustment and does not support clinical testing or a prediction rule.
Source: Medicina
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,654
OpenAlex ID: W7233991608
